CD5- mantle cell lymphoma

American Journal of Clinical Pathology

Volumn 118, Issue 2, 2002, Pages 216-224

  Liu, Zach ^a,c   Dong, Henry Y ^a   Gorczyca, Wojciech ^a   Tsang, Patricia ^a   Cohen, Patti ^a   Stephenson, Christine F ^b   Berger, Carol S ^b   Wu, C Daniel ^a   Weisberger, James ^a  

^a IMPATH Inc   (United States)

^b IMPATH Inc   (United States)

^c MPATH   (United States)

Author keywords

bcl 1; CD5; Flow cytometry; lmmunohistochemistry; Mantle cell lymphoma

Indexed keywords

CD5 ANTIGEN; CELL ANTIGEN;

ARTICLE; CELL STRUCTURE; CHROMOSOME ANALYSIS; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MANTLE CELL LYMPHOMA; MOLECULAR GENETICS; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; AGED; CHEMISTRY; CHROMOSOME 11; FEMALE; GENETICS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; PATHOLOGY;

AGED; AGED, 80 AND OVER; ANTIGENS, CD5; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED;

EID: 0036675170     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/TE56-A43X-29TT-5H8G     Document Type: Article

References (44)

1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
2. Swerdlow SH, Berger F, Isaacson PI, et al. Mantle cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:168-170. World Health Organization Classification of Tumours.
3. Campo E, Raffeld M, Jaffe ES, Mantle-cell lymphoma. Semin Hematol. 1999;36:115-127.
4. Kurtin PJ. Mantle cell lymphoma. Adv Anat Pathol. 1998;5:376-398.
5. Weisenburger DD, Armitage JO. Mantle cell lymphoma: an entity comes of age. Blood. 1996;87:4483-4494.
6. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
7. Kaptain S, Zukerberg LR, Ferry JA, et al. Bcl-1/cyclinD1+ CD5-mantle cell lymphoma [abstract]. Mod Pathol. 1998;11:133a.
8. Bell ND, King JA, Kusyk C, et al. CD5 negative diffuse mantle cell lymphoma with splenomegaly and bone marrow involvement. South Med J. 1998;91:584-587.
9. Stelzer G, Marti G, Hurley A, et al. US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. Cytometry. 1997;30:214-230.
10. Stewart CC, Behm FG, Carey JL, et al. US-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations. Cytometry. 1997;30:231-235.
11. Kaufmann O, Flath B, Spath-Schwalbe E, et al. Immunohisto-chemical detection of CD5 with monoclonal antibody 4C7 on paraffin sections. Am J Clin Pathol. 1997;108:669-673.
12. Bentz M, Plesch A, Bullinger L, et al. t(11;14)-Positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer. 2000;27:285-294.
13. Levy V, Ugo V, Delmer A, et al. Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder. Leukemia. 1999;13:1343-1351.
14. Kaleem Z, White G, Vollmer RT. Critical analysis and diagnostic usefulness of limited immunophenotyping of B-cell non-Hodgkin lymphomas by flow cytometry. Am J Clin Pathol. 2001;115:136-142.
15. Chen CC, Raikow RB, Sonmez-Alpan E, et al. Classification of small B-cell Iymphoid neoplasms using a paraffin section immunohistochemical panel. Appl Immunohistochem Molecul Morphol. 2000;8:1-11.
16. Samaha H, Dumontet C, Ketterer N, et al. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia. 1998;12:1281-1287.
17. Yatabe Y, Suzuki R, Tobinai K, et al. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood. 2000;95:2253-2261.
18. Decaudin D, Salanoubat C, Carde P. Is mantle cell lymphoma a sex-related disease? Leuk Lymphoma. 2000;37:181-184.
19. Watson P, Wood KM, Lodge A, et al. Monoclonal antibodies recognizing CD5, CD10 and CD23 in formalin-fixed, paraffin-embedded tissue: production and assessment of their value in the diagnosis of small B-cell lymphoma. Histopathology. 2000;36:145-150.
20. Wong KF, Chan JK, So JC, et al. Mantle cell lymphoma in leukemic phase: characterization of its broad cytologic spectrum with emphasis on the importance of distinction from other chronic lymphoproliferative disorders. Cancer. 1999;86:850-857.
21. de Leon ED, Alkan S, Huang JC, et al. Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin's Iymphomas of small lymphocytes. Mod Pathol. 1998;11:1046-1051.
22. Aguilera NS, Chu WS, Andriko JA, et al. Expression of CD44 (HCAM) in small lymphocytic and mantle cell lymphoma. Hum Pathol. 1998;29:1134-1139.
23. Dorfman DM, Shahsafaei A. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections. Mod Pathol. 1997;10:859-863.
24. Arber DA, Weiss LM. CD5: a review. Appl Immunohistochem. 1995;3:1-22.
25. Shapiro JL, Miller ML, Pohlman B, et al. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow: a clinicopathologic study of 40 patients. Am J Clin Pathol. 1999;111:477-487.
26. Onciu M, Schlette E, Medeiros LJ, et al. Cytogenetic findings in mantle cell lymphoma: cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities. Am J Clin Pathol. 2001;116:886-892.
27. Chaganti RS, Nanjangud G, Schmidt H, et al. Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: biologic and clinical significance. Semin Hematol. 2000;37:396-411.
28. Bigoni R, Cuneo A, Milani R, et al. Secondary chromosome changes in mantle cell lymphoma: cytogenetic and fluorescence in situ hybridization studies. Leuk Lymphoma. 2001;40:581-590.
29. Cuneo A, Bigoni R, Rigolin GM, et al. Cytogenetic profile of lymphoma of follicle mande lineage: correlation with clinicobiologic features. Blood. 1999;93:1372-1380.
30. Bea S, Ribas M, Hemandez JM, et al. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood. 1999;93:4365-4374.
31. Bosch F, Campo E, Jares P, et al. Increased expression of the PRAD-1/CCND1 gene in hairy cell leukaemia. Br J Haematol 1995;91:1025-1030.
32. Zukerberg LR, Yang WI, Arnold A, et al. Cyclin D1 expression in non-Hodgkin's lymphomas: detection by immunohistochemistry. Am J Clin Pathol. 1995;103:756-760.
33. de Boer CJ, Kluin-Nelemans JC, Dreef E, et al. Involvement of the CCNDl gene in hairy cell leukemia. Ann Oncol. 1996;7;251-256.
34. Sonoki T, Hata H, Kuribayashi N, et al. Expression of PRAD1/cyclin D1 in plasma cell malignancy: incidence and prognostic aspects. Br J Haematol. 1999;104:614-617.
35. Hoechtlen-Vollmar W, Menzel G, Bartl R, et al. Amplification of cyclin D1 gene in multiple myeloma: clinical and prognostic relevance. Br J Haematol. 2000;109:30-38.
36. Yang WI, Zukerberg LR, Motokura T, et al. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol. 1994;145:86-96.
37. De Angeli C, Gandini D, Cuneo A, et al. bcl-1 Rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32). Haematologica. 2000;85:913-921.
38. Cuneo A, Balboni M, Piva N, et al. Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation. Br J Haematol. 1995;90:409-416.
39. Swerdlow SH, Yang WI, Zukerberg LR, et al. Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the bcl1/cyclin D1 gene. Hum Pathol. 1995;26:999-1004.
40. Jadayel D, Matutes E, Dyer MJ, et al. Splenic lymphoma with villous lymphocytes: analysis of bcl-1 rearrangements and expression of the cyclin D1 gene. Blood. 1994;83:3664-3671.
41. Dunphy CH, Perkins SL. Mantle cell leukemia, prolymphocytoid type: a rarely described form. Leuk Lymphoma. 2001;41:683-687.
42. Savilo E, Campo E, Mollejo M, et al. Absence of cyclin D1 protein expression in splenic marginal zone lymphoma. Mod Pathol. 1998;11:601-606.
43. Ferry JA, Yang WI, Zukerberg LR, et al. CD5+ extranodal marginal zone B-cell (MALT) lymphoma: a low grade neoplasm with a propensity for bone marrow involvement and relapse. Am J Clin Pathol. 1996;105:31-37.
44. Ballesteros E, Osborne BM, Matsushima AY. CD5+ low-grade marginal zone B-cell lymphomas with localized presentation. Am J Surg Pathol. 1998;22:201-207.